摘要
美国国立综合癌症网络(National Comprehensive Cancer Network,NCCN)每年更新《NCCN肿瘤临床实践指南—肺癌筛查》,2024年第2版已于2023年10月发布。2024版指南在2023版的基础上对肺癌筛查的肺癌风险因素及评估、初次及后续筛查发现肺结节评估及随访策略、低剂量CT筛查策略和成像方式等方面均进行了部分更新。本文将围绕上述几个更新点进行解读,结合国内相关指南及共识,为我国肺癌筛查提供参考。
The National Comprehensive Cancer Network(NCCN)updates the"NCCN clinical practice guidelines in oncology:Lung cancer screening"annually,and the second edition of 2024 was released in October 2023.The 2024 edition of the guidelines builds on the 2023 edition with some updates on description and assessment of risk factors for lung cancer,evaluation and follow-up of lung nodules found during initial and subsequent screening,and lowdose CT screening protocols and imaging modalities.In this article,we will introduce the above updates and provide reference for lung cancer screening in China by combining the relevant guidelines and consensus in China.
作者
董懂
张亚杰
李鹤成
DONG Dong;ZHANG Yajie;LI Hecheng(Department of Thoracic Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200025,P.R.China)
出处
《中国胸心血管外科临床杂志》
CSCD
北大核心
2024年第9期1253-1257,共5页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金
国家自然科学基金项目(82372855,82072557)
上海交通大学“交大之星”计划“医工交叉研究基金”(YG2023ZD04)
上海市卫生健康委员会新兴交叉领域研究专项(2022JC023)
上海交通大学医学院双百人计划研究型医师(201720055)
科技部国家重点研发项目(2021YFC2500900)。
关键词
肺癌
筛查
指南
解读
Lung cancer
screening
guideline
interpretation
